{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:49Z","timestamp":1786989049859,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004584","name":"Conseil R\u00e9gional de Bretagne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.exer.2019.02.012","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T11:09:07Z","timestamp":1550056147000},"page":"213-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["The bidirectional crosstalk between metastatic uveal melanoma cells and hepatic stellate cells engenders an inflammatory microenvironment"],"prefix":"10.1016","volume":"181","author":[{"given":"Narjes","family":"Babchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Landreville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Coulouarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9183-4235","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Mouriaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2019.02.012_bib1","doi-asserted-by":"crossref","first-page":"49623","DOI":"10.18632\/oncotarget.10418","article-title":"In-depth proteomic profiling of the uveal melanoma secretome","volume":"7","author":"Angi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.exer.2019.02.012_bib2","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1167\/iovs.07-1305","article-title":"17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines","volume":"49","author":"Babchia","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.02.012_bib3","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/jamaophthalmol.2015.1766","article-title":"Potential role of soluble c-Met as a new candidate biomarker of metastatic uveal melanoma","volume":"133","author":"Barisione","year":"2015","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.exer.2019.02.012_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1215\/S1152851704001061","article-title":"The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis","volume":"7","author":"Brat","year":"2005","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.exer.2019.02.012_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000334576","article-title":"Uveal melanoma: the inflammatory microenvironment","volume":"4","author":"Bronkhorst","year":"2012","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.exer.2019.02.012_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/eye.2012.253","article-title":"Inflammation in uveal melanoma","volume":"27","author":"Bronkhorst","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.exer.2019.02.012_bib7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1158\/1541-7786.MCR-10-0437","article-title":"Status of RASSF1A in uveal melanocytes and melanoma cells","volume":"9","author":"Calipel","year":"2011","journal-title":"Mol. Canc. Res."},{"key":"10.1016\/j.exer.2019.02.012_bib8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/1535-7163.MCT-16-0552","article-title":"Co-targeting HGF\/cMET signaling with MEK inhibitors in metastatic uveal melanoma","volume":"16","author":"Cheng","year":"2017","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.exer.2019.02.012_bib9","first-page":"209","article-title":"Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions","volume":"51","author":"Coskun","year":"2004","journal-title":"Neoplasma"},{"key":"10.1016\/j.exer.2019.02.012_bib10","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1158\/0008-5472.CAN-11-3317","article-title":"Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma","volume":"72","author":"Coulouarn","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2019.02.012_bib11","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","article-title":"Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties","volume":"28","author":"Coulouarn","year":"2009","journal-title":"Oncogene"},{"issue":"Thesis 4","key":"10.1016\/j.exer.2019.02.012_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1755-3768.2008.01182.x","article-title":"Receptors for the liver synthesized growth factors IGF-1 and HGF\/SF in uveal melanoma: intercorrelation and prognostic implications","volume":"86","author":"Economou","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2019.02.012_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1755-148X.2012.00971.x","article-title":"Genetic and molecular characterization of uveal melanoma cell lines","volume":"25","author":"Griewank","year":"2012","journal-title":"Pigm. Cell Melanoma Res."},{"key":"10.1016\/j.exer.2019.02.012_bib14","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamaophthalmol.2013.2547","article-title":"Progression of ocular melanoma metastasis to the liver: the 2012 Zimmerman lecture","volume":"131","author":"Grossniklaus","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.exer.2019.02.012_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.humpath.2016.07.012","article-title":"Metastatic ocular melanoma to the liver exhibits infiltrative and nodular growth patterns","volume":"57","author":"Grossniklaus","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.exer.2019.02.012_bib16","first-page":"4479","article-title":"Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway","volume":"9","author":"Herbertz","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.exer.2019.02.012_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bcp.2015.06.009","article-title":"Biological effects of interleukin-6: clinical applications in autoimmune diseases and cancers","volume":"97","author":"Ho","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exer.2019.02.012_bib18","first-page":"2290","article-title":"Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer","volume":"60","author":"Inoue","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2019.02.012_bib19","first-page":"1855","article-title":"The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells","volume":"10","author":"Jiang","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.exer.2019.02.012_bib20","first-page":"58","article-title":"Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer","volume":"1","author":"Johnson","year":"2012","journal-title":"Transl. Gastrointest. Cancer"},{"key":"10.1016\/j.exer.2019.02.012_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.humpath.2017.06.005","article-title":"Inflammatory cell infiltrates in advanced metastatic uveal melanoma","volume":"66","author":"Krishna","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.exer.2019.02.012_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020449","article-title":"Beyond the matrix: the many non-ECM ligands for integrins","volume":"19","author":"LaFoya","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2019.02.012_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2217\/14796694.4.5.629","article-title":"Emerging insights into the molecular pathogenesis of uveal melanoma","volume":"4","author":"Landreville","year":"2008","journal-title":"Future Oncol."},{"key":"10.1016\/j.exer.2019.02.012_bib24","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10585-013-9596-3","article-title":"Host pigment epithelium-derived factor (PEDF) prevents progression of liver metastasis in a mouse model of uveal melanoma","volume":"30","author":"Lattier","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.exer.2019.02.012_bib25","first-page":"39","article-title":"[Interleukin-6 in patients with uveal melanoma]","volume":"113","author":"Likhvantseva","year":"1997","journal-title":"Vestn. Oftalmol."},{"key":"10.1016\/j.exer.2019.02.012_bib26","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00280-008-0881-9","article-title":"Cancer and the tumor microenvironment: a review of an essential relationship","volume":"63","author":"Mbeunkui","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.exer.2019.02.012_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00008390-200108000-00010","article-title":"Serum imbalance of cytokines in melanoma patients","volume":"11","author":"Moretti","year":"2001","journal-title":"Melanoma Res."},{"key":"10.1016\/j.exer.2019.02.012_bib28","first-page":"876","article-title":"Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes","volume":"39","author":"Mouriaux","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.02.012_bib29","first-page":"2837","article-title":"Cyclin-dependent kinase inhibitory protein expression in human choroidal melanoma tumors","volume":"41","author":"Mouriaux","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.02.012_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/bjc.2016.119","article-title":"Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study","volume":"115","author":"Mouriaux","year":"2016","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.exer.2019.02.012_bib31","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1167\/iovs.16-19317","article-title":"Effects of long-term serial passaging on the characteristics and properties of cell lines derived from uveal melanoma primary tumors","volume":"57","author":"Mouriaux","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.02.012_bib32","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","article-title":"Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease","volume":"106","author":"Nishimoto","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exer.2019.02.012_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1321187","article-title":"Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: a pilot study","volume":"6","author":"Qin","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.exer.2019.02.012_bib34","doi-asserted-by":"crossref","first-page":"15017","DOI":"10.1038\/npjbcancer.2015.17","article-title":"Breast cancer cell adhesome and degradome interact to drive metastasis","volume":"1","author":"Rizwan","year":"2015","journal-title":"NPJ Breast Canc."},{"key":"10.1016\/j.exer.2019.02.012_bib35","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-14-2291","article-title":"Interleukin-6 as a therapeutic target","volume":"21","author":"Rossi","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.exer.2019.02.012_bib36","first-page":"851","article-title":"Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth","volume":"53","author":"Sato","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.exer.2019.02.012_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ohc.2004.07.002","article-title":"Uveal melanoma: epidemiologic aspects","volume":"18","author":"Singh","year":"2005","journal-title":"Ophthalmol. Clin. North Am."},{"key":"10.1016\/j.exer.2019.02.012_bib38","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.02.012_bib39","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.28086","article-title":"The involvement of JAK-STAT3 in cell motility, invasion, and metastasis","volume":"3","author":"Teng","year":"2014","journal-title":"JAK-STAT"},{"key":"10.1016\/j.exer.2019.02.012_bib40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02361238","article-title":"Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis","volume":"29","author":"Ueda","year":"1994","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.exer.2019.02.012_bib41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/(SICI)1097-0215(19971114)73:4<470::AID-IJC3>3.0.CO;2-X","article-title":"Melanomas that develop within the eye inhibit lymphocyte proliferation","volume":"73","author":"Verbik","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.exer.2019.02.012_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12307-008-0011-6","article-title":"The prometastatic microenvironment of the liver","volume":"1","author":"Vidal-Vanaclocha","year":"2008","journal-title":"Canc. Microenviron."},{"key":"10.1016\/j.exer.2019.02.012_bib43","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1359-6101(01)00016-8","article-title":"Interleukin-8 and human cancer biology","volume":"12","author":"Xie","year":"2001","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.exer.2019.02.012_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.exer.2019.02.012_bib45","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"123","author":"Yin","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exer.2019.02.012_bib46","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/hep.20488","article-title":"Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice","volume":"40","author":"Yu","year":"2004","journal-title":"Hepatology"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483518308406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483518308406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:28:15Z","timestamp":1762147695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483518308406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":46,"alternative-id":["S0014483518308406"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2019.02.012","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The bidirectional crosstalk between metastatic uveal melanoma cells and hepatic stellate cells engenders an inflammatory microenvironment","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2019.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}